Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • May 2011 | Volume 24 - Issue 5
    By Gerit Mulder, DPM, MS, FRCST, FAPWCA
    6,456 reads | 0 comments | 04/21/11
    It is well known that diabetic foot ulcers contribute to extensive morbidity and mortality in patients with diabetes.1 Advanced biological and topical drug treatments have been introduced over the last two decades in an attempt to expedite wound closure, thereby reducing the risk of infection, amputation and other complications. These products include topical growth factors (Regranex®, Systagenix) as well as bioengineered living cell products, with the most frequently applied being Apligraf® (Organogenesis) and Dermagraft® (Advanced Biohealing). ... continue reading

    5,876 reads | 0 comments | 04/21/11
    Study Finds Good Long-Term Results With First MPJ Implants By Brian McCurdy, Senior Editor A n abstract presented at the recent American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference notes good long-term results with a double-stem silicone first MPJ implant with titanium grommets. ... continue reading
    Moderator: Warren S. Joseph, DPM, FIDSA Panelists: Allen Jacobs, DPM, FACFAS, Mark Kosinski, DPM, FIDSA, Adam Landsman, DPM, FACFAS, PhD, Bryan Markinson, DPM, FASPD, and Richard Pollak, DPM, MS, FACFAS
    17,874 reads | 0 comments | 04/20/11
    Given the prevalence of onychomycosis and the emergence of laser therapy, these panelists review their approaches to managing onychomycosis, discuss ethical considerations with non-FDA approved modalities and emphasize the importance of establishing realistic patient expectations. ... continue reading